September is AFib Awareness Month!

hrs-2013 (1)

Atrial Fibrillation — also known as AFib or AF — is the most common arrhythmia. It affects more than 2.5 million American adults and 4.5 million people living in the European Union, and accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. It is characterized by a rapid and irregular heartbeat caused when the […]

Updates from HRS 2013!

hrs-2013

Late-Breaking Clinical Trials Session Presents Practice-Changing Data Current practice guidelines typically recommend discontinuing oral anticoagulation with warfarin for patients undergoing cardiac procedures, but two studies from Thursday’s Late-Breaking Clinical Trials session suggest that patients may do better if warfarin therapy is continued. Discontinuation of oral warfarin carries a 13-fold risk for periprocedural stroke and hemorrhagic […]